Prices delayed by at least 15 minutes | Print
Vaxart (VXRT)
Common SharesThis share can be held in a Dealing accountISALifetime ISAJISASIPP
Company profile
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.
Address
2500 Northwinds Parkway
Suite 100
Alpharetta
GA
USA
30009
Telephone
+1 678 2213343
Forecast key dates
| Name | Key Date |
|---|---|
| Vaxart Inc Fourth Quarter Earnings Conference Call for 2024 | 2025-03-14T16:30:00 |
| Vaxart Inc Fourth Quarter Earnings Results for 2024 | 2025-03-14T00:00:00 |
| Vaxart Inc Annual Report for 2024 | 2025-03-14T00:00:00 |
| Vaxart Inc Third Quarter Earnings Conference Call for 2024 | 2024-11-01T16:30:00 |
| Vaxart Inc Third Quarter Earnings Results for 2024 | 2024-11-01T00:00:00 |
| Vaxart Inc Second Quarter Earnings Conference Call for 2024 | 2024-08-02T16:30:00 |
| Vaxart Inc Second Quarter Earnings Results for 2024 | 2024-08-02T00:00:00 |
| Vaxart Inc Annual General Meeting for 2024 | 2024-06-26T10:00:00 |
| Vaxart Inc First Quarter Earnings Conference Call for 2024 | 2024-05-03T16:30:00 |
| Vaxart Inc First Quarter Earnings Results for 2024 | 2024-05-03T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Vaxart Inc First Quarter Earnings Conference Call for 2024 | 2024-05-03T16:30:00 |
| Vaxart Inc First Quarter Earnings Results for 2024 | 2024-05-03T00:00:00 |
| Vaxart Inc Fourth Quarter Earnings Conference Call for 2023 | 2024-03-14T16:30:00 |
| Vaxart Inc Fourth Quarter Earnings Result for 2023 | 2024-03-14T00:00:00 |
| Vaxart Inc Annual Report for 2023 | 2024-03-14T00:00:00 |
| Vaxart Inc Third Quarter Earnings Conference Call for 2023 | 2023-11-02T16:30:00 |
| Vaxart Inc Third Quarter Earnings Result for 2023 | 2023-11-02T00:00:00 |
| Vaxart Inc Second Quarter Earnings Conference Call for 2023 | 2023-08-03T16:30:00 |
| Vaxart Inc Second Quarter Earnings Result for 2023 | 2023-08-03T00:00:00 |
| Vaxart Inc Annual General Meeting for 2023 | 2023-06-26T10:00:00 |
| Vaxart Inc First Quarter Earnings Conference Call for 2023 | 2023-05-04T16:30:00 |
| Vaxart Inc First Quarter Earnings Result for 2023 | 2023-05-04T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.